Dr. Martine Rothblatt’s titles include lawyer, biotech company founder, satellite radio innovator and author. Rothblatt serves as chairman and chief executive officer of United Therapeutics, a biotech company focused on treating rare lung diseases. She started United Therapeutics to save the life of one of her daughters, and after coming out as transgender. Her management focus is making and marketing drug-device combination products, proving and promoting proprietary pharmaceuticals, and manufacturing transplantable organs. She designed and set dual-pilot speed, altitude, and endurance records in the world’s first electric helicopter, now being optimized for autonomous organ delivery.
Before founding United Therapeutics in 1996, Rothblatt created and led Sirius Satellite Radio, now Sirius XM, as its chairman and CEO. She also launched other satellite systems for navigation and international television broadcasting. Her patented inventions cover aspects of satellite radio, prostacyclin biochemistry and cognitive software.
Rothblatt earned law and M.B.A. degrees from the University of California, Los Angeles, and a Ph.D. in medical ethics from the Royal London School of Medicine and Dentistry.
Rothblatt serves on the National Academy of Sciences Committee on Science, Technology and Law. She represented the radio astronomy community before the Federal Communications Commission in efforts to secure quiet frequency bands for astrophysics research as a member of the National Academy of Sciences Committee on Radio Frequencies. She also spearheaded the International Bar Association’s efforts to present a draft Human Genome Treaty to the United Nations.
Her recent books are on organ transplantation (Your Life or Mine), gender identity (Transgender to Transhuman) and cyberethics (Virtually Human).